New Drugs in the Treatment of Mood Disorders

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 1995

Study Completion Date

May 31, 2001

Conditions

Anxiety DisorderMood DisorderPsychotic Disorder

Interventions

DRUG

Lamotrigine (Lamictal® (Registered Trademark)

DRUG

Gabapentin (Neurontin® (Registered Trademark))

Trial Locations (1)

National Institute of Mental Health (NIMH), Bethesda

All Listed Sponsors

lead

National Institute of Mental Health (NIMH)

NIH

NCT00001482 - New Drugs in the Treatment of Mood Disorders | Biotech Hunter | Biotech Hunter